Singapore: The European Medicine Agency (EMA) recommended restriction in the use of the osteoporosis medicine Protelos/Osseor, following an assessment of data showing... Read more
Singapore: Novartis is going to invest $160 million (CHF150 million) until 2020 to bolster its production site near Geneva. The firm was contemplating a shut down... Read more
Singapore: Novozymes, bioinnovation and industrial enzymes, has reported five percent growth in first quarter of 2013. "Overall, the first quarter was as expected.... Read more
Singapore: European Medicines Agency has published the initial list of medicines that are subject to additional monitoring. This represents an important deliverable... Read more
Singapore: Novartis revealed that it would pay Dr Joerg Reinhardt, the firm's incoming chairman of the board (effective August 1, 2013), a total annual compensation... Read more
Singapore: Phylogica has been granted a new European patent (no. 1793841) entitled: ‘Peptide inhibitors of c-Jun dimerization and uses thereof'. This international... Read more
Singapore: Germany-based Oncotest and Debiopharm, a Swiss-based global biopharmaceutical group, have completed first biomarker projects at Oncotest. The pharmacological... Read more
Singapore: Bionomics has initiated manufacturing activities for BNC101, its lead anti-cancer stem cell candidate following completion of key preclinical studies.... Read more
Singapore: AstraZeneca and Bind Therapeutics entered into a strategic collaboration to develop and commercialize Accurin, a targeted and programmable cancer nanomedicine... Read more
Survey Box
Subscribe to BioSpectrum Asia digital mag at an attractive price of US $49.99 a year
(Includes all 24 regular & special issues @ fortnightly frequency)
Australia
China
India
Japan
Korea
Malaysia
New Zealand 
Singapore
Taiwan
Thailand
